Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/1996
08/21/1996CN1129216A Hydroxamic acid derivatives with tricylic substitution
08/21/1996CN1129113A Agent with special effect for curing Acquired Immunity Deficiency Syndrome
08/21/1996CN1129102A Catechol diether compounds as inhibitors of TNF release
08/20/1996US5547980 Antiallergens, bronchodilator
08/20/1996US5547972 1-(arlalkylaminoalkyl) imidazole derivatives
08/20/1996US5547959 For treatment of the autoimmune disease systemic lupus erythematosus
08/20/1996US5547946 Topical pharmaceutical compositions for respiratory allergies
08/20/1996US5547853 CD2-binding domain of lymphocyte function associated antigen 3
08/20/1996US5547852 Composition containing the P40 subunit of interleukin-12
08/15/1996WO1996024844A1 Method of diagnosing immune diseases
08/15/1996WO1996024668A1 Human chemokine beta-11 and human chemokine alpha-1
08/15/1996WO1996024613A1 A process for preparing certain aza cyclohexapeptides
08/15/1996WO1996024579A1 15-deoxyspergualin analogs, therapeutical use thereof, and method for preparing same
08/15/1996WO1996024371A1 Multifunctional enzyme
08/15/1996WO1996024357A1 Novel glucocorticoid response elements
08/15/1996WO1996024350A1 Pharmaceutical preparations for tumour necrosis factor (tnf) inhibition
08/15/1996WO1996024343A1 Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection
08/15/1996WO1996018391A3 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
08/15/1996WO1996013590A3 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
08/15/1996WO1996011685A3 Use of indole derivatives for the treatment of various diseases
08/15/1996CA2212645A1 Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection
08/15/1996CA2212533A1 Multifunctional enzyme
08/15/1996CA2212379A1 Novel glucocorticoid response elements
08/15/1996CA2211621A1 Methods and compositions for regulation of cd28 expression
08/15/1996CA2187281A1 15-deoxyspergualin analogs, their use in therapeutics and their method of preparation
08/14/1996EP0726062A2 Center dispense suture package
08/14/1996EP0725824A1 Immunodominant human t-cell epitopes of hepatitis c virus
08/14/1996EP0725796A1 Growth differentiation factor-10
08/14/1996EP0725794A1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives
08/14/1996EP0725654A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
08/14/1996EP0725651A1 Hemoregulatory peptides
08/14/1996EP0725637A1 Parenteral busulfan for treatment of malignant disease
08/14/1996EP0725635A1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
08/14/1996EP0725629A1 Liposomal defensins
08/14/1996EP0618913B1 Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
08/14/1996EP0527762B1 Inhibition of allograft and concordant xenograft rejection
08/14/1996CN1128987A Novel intermediates for prepn. of antihisatminic 4-diphenylmethyl/diphenymethoxy piperidine derivatives
08/14/1996CN1128948A Pharmaceutical composition for immounomodulating and adjuvant treatment
08/14/1996CN1128671A Cyclosporin soft capsule composition
08/13/1996US5545750 Retroviral protease inhibiting compounds
08/13/1996US5545723 Amino acid sequence where valine at position 101 is replaced with phenylalanine, tyrosine, tryptophan or histidine; diplayes an antiviral activity, that is atleast partially neutralized by antibodies to wild type interferon-beta
08/13/1996US5545718 Synthetic peptides of the conjugate of ubiquitine and H2A histone
08/13/1996US5545662 Used to accelerate recovery from neutropenia accompanying radio or chemotherapy, bone marrow transplantation, or infections
08/13/1996US5545641 Methods of inhibiting physiological conditions associated with an excess of bradykinin
08/13/1996US5545640 Viricides, hiv; aids
08/13/1996US5545637 Process for preparing pharmaceutical compositions containing crystalline anhydrous mycophenolate mofetil salts
08/13/1996US5545633 Triplet-sensitized photoisomerization; dehydration; protecting; deprotecting; separation
08/13/1996US5545619 Autoimmune diseases; transplant rejection, reduction in tissue damage associated with myocardial infarctions and strokes; medical diagnosis
08/13/1996US5545536 Colony-stimulating factor derivatives
08/13/1996US5545405 Administering recombinant antibody glycosylated by chinese hamster ovary cell
08/13/1996US5545404 Method for treating a mammal suffering from a T-cell medicated disorder with a CHO-Glycosylated antibody
08/13/1996US5545403 Method for treating a mammal by administering a CHO-glycosylated antibody
08/11/1996CA2169152A1 Center dispense suture package
08/08/1996WO1996023893A1 Immunosuppressive and tumour-suppressive bone marrow factor
08/08/1996WO1996023870A1 A method of preparing an undifferentiated cell
08/08/1996WO1996023787A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/07/1996EP0725077A1 Novel glycoproteins, process for preparation thereof, and pharmaceutical composition
08/07/1996EP0724632A1 Stem cell proliferation factor
08/07/1996EP0724594A1 Regulation of transcription factor, nf-il6/lap
08/07/1996EP0724581A1 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
08/07/1996EP0724570A1 Amidino derivatives useful as nitric oxide synthase inhibitors
08/07/1996EP0724456A1 Antibodies to cd40
08/07/1996EP0724452A1 PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSPORINE A AND $g(a)-TOCOPHEROL
08/07/1996EP0724435A1 Amidino derivatives useful as nitric oxide synthase inhibitors
08/07/1996EP0724387A1 Treatment of chronic anti-inflammatory diseases by angiotension ii receptor antagonists
08/07/1996EP0527813B1 T-CEL LYMPHOMA cDNA CLONES
08/07/1996CN1128263A Pyrrolopyrimidine derivatives having pharmacological activity
08/07/1996CN1128262A Substituted biphenyl isoxazole sulfonamides
08/07/1996CN1128260A New piperidine compounds, process for their preparation and the pharmaceutical compositions which contain them
08/07/1996CN1032469C Method for processing heterocyclic amide derivant new physical morphogenesis
08/07/1996CA2168827A1 Glycoproteins, process for preparation thereof, and pharmaceutical composition
08/06/1996US5543418 Innovative technique for immunosuppresion involving administration of rapamycin loaded formed blood elements
08/06/1996US5543410 Pharmacological use of phthaloylhydrazide derivatives; combination and application thereof
08/06/1996US5543408 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
08/06/1996US5543320 Genetic engineering
08/06/1996US5543140 Method and use of IL-1α
08/01/1996WO1996023071A2 MONOCLONAL ANTIBODIES SPECIFIC FOR DIFFERENT EPITOPES OF HUMAN gp39 AND METHODS FOR THEIR USE IN DIAGNOSIS AND THERAPY
08/01/1996WO1996023068A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses
08/01/1996WO1996023067A1 Human interleukin-1 receptor accessory protein
08/01/1996WO1996022966A1 Cell adhesion inhibitors
08/01/1996WO1996022787A1 Recombinant human alpha-fetoprotein and uses thereof
08/01/1996WO1996022778A1 Derivatives of succinamide and their use as metalloproteinase inhibitor
08/01/1996WO1996022772A1 Method for treating multiple sclerosis
08/01/1996WO1996022769A1 Method for treating multiple sclerosis
08/01/1996CA2211181A1 Cell adhesion inhibitors
08/01/1996CA2210724A1 Human interleukin-1 receptor accessory protein
08/01/1996CA2210662A1 Method for treating multiple sclerosis
08/01/1996CA2210566A1 Method for treating multiple sclerosis
08/01/1996CA2210419A1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy
07/1996
07/31/1996EP0723962A1 Arylalkyl-thiadiazinones
07/31/1996EP0723959A1 Heterocyclic compounds as tachykinin receptor antagonists, process for their preparation and pharmaceuticals containing them
07/31/1996EP0723958A1 Synthesis of substantially pure terfenadine derivatives
07/31/1996EP0723556A1 Fas antagonists and uses thereof
07/31/1996EP0723553A1 Compounds useful in anti-allergy treatment
07/31/1996EP0723552A1 Oligopeptides derived from c-reactive protein fragments
07/31/1996EP0723458A1 Immune modulation with class ii alpha-chain fragments
07/31/1996EP0723455A1 Methods of inhibiting phagocytosis
07/31/1996EP0723454A1 Novel tripeptides useful in immune and cns therapy
07/31/1996EP0723446A1 Treatment of allergic disorders with terfenadine carboxylate
07/31/1996EP0723440A1 Therapeutic delivery compositions and methods of use thereof
1 ... 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 ... 1172